SBLK heads into its Q2 earnings today with a one-sided insider selling pattern that stands out against an otherwise constructive price backdrop.
The COO has been the most active insider, selling shares across six separate transactions since mid-May — totalling roughly 84,000 shares at prices ranging from $26 to $29. A director added another 20,000 shares sold in June. Net insider activity over the past 90 days amounts to just over $2.8 million in sales. The stock itself has recovered well, up 11% over the past month to $27.96, and the broader dry bulk peer group moved in the same direction this week — GNK added 2.3% on the week, SB gained 3.7%, and DSX surged 15% — making the insider selling more conspicuous against a rising tide.
The fundamental debate centres on whether the rate recovery visible in Q4 bookings can more than offset the soft patches that tripped up recent quarters. Jefferies holds a Buy with a $31 target, raised from $29 in late May — the most recent analyst action and the only meaningful coverage update in the past few months. The bull case points to a fortress balance sheet: cash reserves at $452.5 million, a net loan-to-value ratio of just 21%, and Q4 bookings at their strongest since early 2024. Bears note the Q3 miss — adjusted EPS of $0.28 against a $0.32 consensus, EBITDA of $86.8 million versus $97.6 million expected — and point to Kamsarmax rates down roughly 15% from their July 2025 peak as a persistent drag on the largest single revenue segment. Valuation offers little immediate edge: the stock trades at roughly 7.7x trailing earnings and 6.2x EV/EBITDA, modest multiples but not screaming cheap for a cyclical carrier.
Short interest is barely a factor heading into the print. Bears have almost entirely exited — SI has fallen 43% over the past month to just under 1% of the free float. Borrow costs are negligible at 0.88%, and availability is extraordinarily loose, with over 13 million shares available to lend against just over 1 million currently short. One genuinely interesting shift in options: the put/call ratio has dropped to 3.83, almost two standard deviations below its 20-day average of 4.66, near the lowest reading of the past year. That is a notable shift toward calls relative to recent history — options traders appear less defensive than they have been throughout the summer, even as insiders were selling.
Today's print will test whether the Q4 rate recovery story is real enough to justify the 11% one-month re-rating, or whether the insider selling and the lingering Kamsarmax weakness were the better signal all along.
See the live data behind this article on ORTEX.
Open SBLK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
